TY - JOUR
T1 - Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis
AU - Cuzzocrea, Salvatore
AU - McDonald, Michelle C.
AU - Mazzon, Emanuela
AU - Dugo, Laura
AU - Lepore, Valeria
AU - Fonti, Maria Teresa
AU - Ciccolo, Antonio
AU - Terranova, Maria Luisa
AU - Caputi, Achille P.
AU - Thiemermann, Christoph
PY - 2000/10/6
Y1 - 2000/10/6
N2 - Inflammatory bowel disease is characterized by oxidative and nitrosative stress, leukocyte infiltration, and up-regulation of intercellular adhesion molecule 1 (ICAM-1) expression in the colon. The aim of the present study was to examine the effects of tempol, a membrane-permeable radical scavenger, in rats subjected to experimental colitis. Colitis was induced in rats by intracolonic instillation of dinitrobenzene sulfonic acid. Rats experienced bloody diarrhea and significant loss of body weight. At 4 days after the administration of dinitrobenzene sulfonic acid, the colon injury comprised of large areas of mucosal necrosis. Neutrophil infiltration (measured as increase in myeloperoxidase activity in the mucosa) was associated with up-regulation of ICAM-1 and expression of P-selectin and high levels of malondialdehyde (an indicator of lipid peroxidation). Immunohistochemistry for nitrotyrosine and poly (ADP-ribose) synthetase showed an intense staining in the inflamed colon. Treatment of rats with tempol (15 mg/kg daily i.p.) significantly reduced the appearance of diarrhea and the loss in body weight. This was associated with a remarkable amelioration of the disruption of the colonic architecture as well as a significant reduction in the degree of both neutrophil infiltration and lipid peroxidation in the inflamed colon. Tempol also reduced the appearance of nitrotyrosine and poly (ADP-ribose) synthetase immunoreactivity in the colon as well as the up-regulation of ICAM-1 and P-selectin. The results of this study suggest that membrane-permeable radical scavengers, such as tempol, exert beneficial effects in experimental colitis and may, hence, be useful in the treatment of inflammatory bowel disease. Copyright (C) 2000 Elsevier Science B.V.
AB - Inflammatory bowel disease is characterized by oxidative and nitrosative stress, leukocyte infiltration, and up-regulation of intercellular adhesion molecule 1 (ICAM-1) expression in the colon. The aim of the present study was to examine the effects of tempol, a membrane-permeable radical scavenger, in rats subjected to experimental colitis. Colitis was induced in rats by intracolonic instillation of dinitrobenzene sulfonic acid. Rats experienced bloody diarrhea and significant loss of body weight. At 4 days after the administration of dinitrobenzene sulfonic acid, the colon injury comprised of large areas of mucosal necrosis. Neutrophil infiltration (measured as increase in myeloperoxidase activity in the mucosa) was associated with up-regulation of ICAM-1 and expression of P-selectin and high levels of malondialdehyde (an indicator of lipid peroxidation). Immunohistochemistry for nitrotyrosine and poly (ADP-ribose) synthetase showed an intense staining in the inflamed colon. Treatment of rats with tempol (15 mg/kg daily i.p.) significantly reduced the appearance of diarrhea and the loss in body weight. This was associated with a remarkable amelioration of the disruption of the colonic architecture as well as a significant reduction in the degree of both neutrophil infiltration and lipid peroxidation in the inflamed colon. Tempol also reduced the appearance of nitrotyrosine and poly (ADP-ribose) synthetase immunoreactivity in the colon as well as the up-regulation of ICAM-1 and P-selectin. The results of this study suggest that membrane-permeable radical scavengers, such as tempol, exert beneficial effects in experimental colitis and may, hence, be useful in the treatment of inflammatory bowel disease. Copyright (C) 2000 Elsevier Science B.V.
KW - Colon damage
KW - Dinitrobenzene sulfonic acid
KW - Free radical
KW - Inflammation
KW - Nitric oxide (NO)
KW - Peroxynitrite
KW - Poly (ADP-ribose) synthetase
UR - http://www.scopus.com/inward/record.url?scp=0034613306&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034613306&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(00)00623-3
DO - 10.1016/S0014-2999(00)00623-3
M3 - Article
C2 - 11011044
AN - SCOPUS:0034613306
SN - 0014-2999
VL - 406
SP - 127
EP - 137
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -